Company

Phare Bio

Biotechnology Research A Looming Crisis in Antibiotic Resistance 12 employees

Employees: 12
Contacts: 2
Emails: 2
Phones: 1

www.pharebio.org LinkedIn Crunchbase

Phare Bio Overview

Headquarters: A Looming Crisis in Antibiotic Resistance
Website: www.pharebio.org
Industry: Biotechnology Research
Employees: 12
Founded: 2020
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology Infectious Disease Anti-infectives

About Phare Bio

Phare Bio is an ambitious new social venture using novel AI and deep learning for antimicrobial development in partnership with Jim Collins' lab at MIT. Started in 2021 to address a looming crisis in antibiotic resistance, Phare is the recipient of Audacious Project prize to support big and potentially powerful solutions to the world’s most urgent challenges. View community guidelines here: https://bit.ly/PhareBio_CommunityGuidlines

Phare Bio Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Phare Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Claire Nishioka Robinson	Senior Director, Head of Business	New York, United States	View
Samuel Mattern-Schain	Organic Chemist with Expertise	Knoxville, Tennessee, United States	Email
Akhila Kosaraju, M.d.	CEO and President, Phare Bio		View
Leanne Minall	VP of Science	Greater Boston, United States	Email Phone